JPRN-UMIN000017523
Recruiting
未知
Prospective and Non-interventional registry to Investigate Effectiveness and Safety of Rivaroxaban on Prevention of Stroke and Systemic Embolism in Patients with Non-valvular Atrial Fibrillation at Fukui Red Cross Hospital - Prospective and Non-interventional registry to Investigate pharmacokinetics (for the coagulation/fibrinolysis status and vascular function) and Safety of Rivaroxaban in Patients with Non-valvular Atrial Fibrillation (FENIX Registry)
Fukui Red Cross Hospital0 sites100 target enrollmentMay 12, 2015
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- on-valvular atrial fibrillation (In the present study, non-valvular atrial fibrillation refers to atrial fibrillation without a history of prosthetic valve replacement or mitral valve stenosis.)
- Sponsor
- Fukui Red Cross Hospital
- Enrollment
- 100
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •The following patients in whom rivaroxaban is contraindicated for use \- Patients with a history of allergies to the ingredients contained in this drug \- Patients having a hemorrhagic event (intracranial hemorrhage, gastrointestinal hemorrhage or other clinically significant hemorrhagic events) \- Patients having liver disease complicated with coagulation disorder or those having moderate or worse liver disorder (Grade B or C in accordance with the Child\-Pugh classification) \- Patients having renal failure (creatinine clearance \<15 mL/min) \- Women who are or are likely to be pregnant \- Patients who are treated with HIV protease inhibitors (including ritonavir, atazanavir and indinavir) \- Patients who are treated with oral or injectable formulations of azole antifungal drugs (including itraconazole, voriconazole and ketoconazole (excluding fluconazole)) \-Patients with acute bacterial endocarditis \- Patients have remaining effects are received with other anticoagulation therapy \-Patients are unstable state of blood pressure(18/120mmHg\>)
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
A pan-india non-interventional virtual registry evaluating the prophylactic efficacy of different regimens against SARS-CoV2 infection (COVID-2019) in asymptomatic health care workersCTRI/2020/04/024482Zifo RnD Solutions391
Recruiting
Not Applicable
on-interventional, Prospective register concerning treatment of cervical cancer FIGO IB - IIA by nerve-sparing total mesometrial resection and therapeutic lymphadenectomy (TMMR/tLNE) according to M. Hoeckel.C53Malignant neoplasm of cervix uteriDRKS00004793niversitätsklinikum Essen300
Recruiting
Not Applicable
A multi-center and non-interventional registry of Brentuximab Vedotin in patients with relapsed or refractory anaplastic large cell lymphoma or classical Hodgkin lymphomaKCT0003789Samsung Medical Center150
Recruiting
Not Applicable
A multi center and non interventional registry of Korean Medicine Treatment for Patients with Shoulder pain.KCT0007128Kyung Hee University Oriental Medicine Hospital at Gangdong400
Recruiting
Not Applicable
Prospective non-interventional registry study entitled:Peripartum outcome in vaginally targeted final pelvic births and influencing factorsO32.1Maternal care for breech presentationDRKS00025030Zentrum für Frauenheilkunde und Geburtshilfe Universitätsklinikum Frankfurt am Main1,500